The most recent industry report from Future Market Insights estimates that the global viral RNA extraction kits market will grow at a compound annual growth rate (CAGR) of nearly 7.2% over the course of the forecast period, with a valuation of US$ 421.4 million by the end of 2033. The market was valued at US$ 200.6 million in 2022.
Viral RNA extraction is crucial in molecular diagnostic testing for infectious diseases caused by RNA viruses. The increasing demand for accurate and rapid testing for viral infections, such as COVID-19, influenza, hepatitis, HIV, and other emerging viral diseases drives the market.
Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12149
Significant progress has been made in cancer diagnosis using next-generation sequencing (NGS) technology to better understand the genomic profile of patients and tumour types. In recent years, NGS-based diagnostics profiling somatic mutations in tumours have shown clinical utility and favorable cost-effectiveness in cancer treatment.
As more effort is being spent on the extraction of biomolecules, continual technological changes are happening these days to improve the extraction process for targeted molecules. Automated extraction systems tend to be specifically designed instruments that help simplify and increase the output of nucleic acid extraction.
- The QIAcube Connect system fully automates QIAGEN spin-column extraction and purification protocols through a user-friendly interface. The automated system facilitates the utilization of over 80 QIAGEN kits, which includes more than 140 standard protocols commonly employed for various applications.
In general, the aforementioned factors are facilitating the expansion of the viral RNA extraction kit market and are anticipated to sustain the need for efficient and inventive alternatives in the predictable future.
Key Takeaways:
- Nasal washes and swab is the leading segment as sample type among patients and professionals, and held about 9% revenue share in the global market in 2022 due to their high efficacy and specificity.
- By application, disease diagnosis is leading in the global viral RNA extraction kit market. It is expected to continue to do so with a projected CAGR rate of 5% during the forecasted years because viral RNA extraction kits play a crucial role in enabling accurate viral detection and diagnosis, making disease diagnosis the most widely used application for these kits.
- By end user, diagnostic laboratories are leading in the global viral RNA extraction kit market and are expected to continue to do so with a projected CAGR of 6% during the forecasted years due to the ease availability of testing kits in the diagnostic laboratories.
- By region, North America is leading in the global viral RNA extraction kit market. It is expected to continue to do so with a projected CAGR of 8% during the forecasted years due to research and development and academic and educational institutions.
Viral RNA Extraction Kit Market Competition
Key players in the viral RNA extraction kit market commonly employ strategic initiatives such as partnerships, acquisitions, and mergers to enhance their business operations. Prominent industry participants focus on implementing tactics such as augmenting revenue and leveraging cutting-edge technology to develop unique offerings.
- In June of 2020, Omega Bio-tek, Inc. announced the Mag-Bind a Viral RNA Xpress Kit. This kit facilitates the rapid and dependable isolation of Viral RNA from swab specimens.
- Beckman Coulter announced the release of the RNAdvance Viral XP Extraction Kit in November of 2020. The validation of the kit for RNA extraction from swab samples in high-throughput research processes has been conducted by iRepertoire, and it has been determined to be suitable. The product in question is intended for utilization in the context of quantitative real-time polymerase chain reaction (qRT-PCR).
Key Players :
- QIAGEN N.V.
- Omega Bio-Tek
- Thermo Fisher Scientific
- F.Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories
- F.Hoffmann-La Roche Ltd.
- Promega Corporation
- Genaxxon Bioscience GmbH
- Agilent Technologies
Key Segmentation:
By Product Type:
- Kits & panel
- Solutions & Reagents
- Instruments & devices
By Type:
- Messenger RNA Isolation
- Circulating Nucleic Acid Purification
- MicroRNA Isolation
- PCR Cleanup
By Method:
- Guanidinium-acid-phenol isolation
- Silica technology
- Density gradient centrifugation
- Magnetic bead technology
- Lithium chloride & urea purification
- Column chromatography
- Non-column isolation
By Indication:
- Viral genotyping, epidemiology, & infectious disease research
- Drug Development (New product development)
- Personalized Medicine approach
- Animal Research (specimen or species research)
- Agriculture & horticulture
- Diagnostics
By End-user:
- Diagnostic centers or labs
- Research Institutes (Educational centers)
- Biotechnological & pharmaceutical organizations
- CROs (Contract Research Organizations)
Region
- North America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-12149
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
